NCT05584553 - PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm and JuggerLoc™ in the Shoulder | Biotech Hunter

Enrollment

206

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Bankart LesionsSLAP LesionAcromioclavicular; DislocationCapsular Shift/Capsulolabral ReconstructionDeltoid RepairRotator Cuff Tear RepairBiceps Tendon Disorder

Interventions

DEVICE

ToggleLoc 2.9 mm soft tissue device

The ToggleLoc 2.9 mm Soft Tissue devices consist of non-resorbable devices intended to aid in arthroscopic and orthopaedic reconstructive procedures requiring soft tissue to bone fixation.

DEVICE

JuggerLoc soft tissue device

The JuggerLoc Soft Tissue devices consist of non-resorbable devices intended to aid in arthroscopic and orthopaedic reconstructive procedures requiring soft tissue to bone fixation.

Trial Locations (3)

28223

Hospital Universitario Quirónsalud, Madrid

63376

Advanced Bone and Joint, City of Saint Peters

03184

Centro Médico Quirónsalud, Alicante